The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

talked about weight loss injections, hormone balancing, and the options that are available to you. GLP-1 injections are one popular injection that some people are using to lose weight. However ...

Depending on your individual situation, other weight loss medications (like weight loss pills) or bariatric surgery might be worth exploring. In any case, your healthcare provider is there to ...

Early tests showed patients using the tablet had a 16 percent weight loss. The pharmaceutical company has confirmed that they are seeking approval for their new pill form in the United States.

Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral weight loss candidate. BREAKING: Trump abruptly fires Joint Chiefs Chairman ...

An unexplained weight loss happens when you lose a significant amount of weight without a change in diet, exercise, or lifestyle. There seems no reason for it, which is why it's sometimes called ...

Modern birth control pills don’t contain enough hormones to cause significant weight gain. If you’ve gained unexpected weight after starting the pill, it’s likely unrelated to your choice of ...